Health News

At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.


FDA Approves New Parkinson's Treatment
The US Food and Drug Administration (FDA) has approved a new treatment for Parkinson's disease, and it came three months ahead of schedule.
Even Lighting Up Occasionally May Spark Health Concerns
Teens may have a tendency to think they're bulletproof, but even an occasional cigarette can be harmful to their health.
Going Under? Talk About Your Worries
Although most people don't have any problems receiving anesthesia, many have worries about going under. An anesthesiologist can allay many of those worries.
The Healing Power of Quitting Smoking
One more entry on the list of reasons to quit smoking: quitting may help your body heal its wounds. Many doctors, however, may not be talking about this benefit with their patients who smoke.
This Surgery Could Reverse Type 2 Diabetes
Unlike diamonds, type 2 diabetes doesn't have to be forever. Weight loss surgery may help patients reverse type 2 diabetes.
FDA Review of Possible Risks of Pain Medicine Use During Pregnancy
FDA is aware of and understands the concerns arising from recent reports questioning the safety of prescription and over-the-counter (OTC) pain medicines when used during pregnancy.
'Father of Modern Gospel' Music Passes On
Andraé Crouch, 72, known as the "father of modern gospel," died Jan. 8 in the Los Angeles area after being hospitalized for a heart attack.
Hysterectomy Not Always the Only Option
Why have major surgery when a less intensive treatment option might do the trick? This complex question might be one women and their doctors need to discuss.
FDA Approves Anti-Clotting Drug Savaysa
The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.
Regeneron and Sanofi Announce Positive Results for Cholesterol Drug
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that two new ODYSSEY trials, which are the first Phase 3 trials to assess alirocumab administered every four weeks, met their primary efficacy endpoints.
<< first297298299300301302303304305last >>

REFINE